Impaired neutrophil-mediated cell death drives Ewing's Sarcoma in the background of Down syndrome

Area of Science:

• Pediatric Oncology
• Genetics
• Immunology

Background:

• Ewing sarcoma (EWS) is rare in children with Down syndrome (DS).
• Detailed characterization of solid tumors in DS patients is lacking.
• This study investigates a unique case of chemo-resistant mediastinal EWS in a young DS child.

Purpose of the Study:

• To characterize a chemo-resistant mediastinal EWS in a pediatric Down syndrome patient.
• To investigate the genetic and molecular mechanisms driving tumor development and progression.
• To understand the role of inherited immune deficiencies in EWS in DS.

Main Methods:

• Utilized advanced sequencing approaches for comprehensive tumor characterization.
• Analyzed the genetic makeup and molecular pathways of the EWS tumor.
• Investigated the impact of the patient's myeloperoxidase deficiency on tumor biology.

Main Results:

• The EWS tumor exhibited neuroectodermal differentiation driven by the EWSR1-FLI1 fusion.
• The patient's inherited myeloperoxidase deficiency led to impaired neutrophil-mediated cell death and genomic instability.
• Tumor evolution was marked by near-haploidization, overexpression of pro-inflammatory cytokines, and recruitment of defective neutrophils.

Conclusions:

• This case highlights a novel mechanism of EWS development and progression in a Down syndrome patient.
• Inherited immune deficiencies can significantly influence cancer evolution.
• Further research is needed to understand the interplay between genetic syndromes and pediatric cancers.